Table 32 Antimalarial activity of benzimidazole derivatives 30a and 31 g
From: Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review
Comp. | Minimum inhibitory concentration (IC50 µg/mL) |
|---|---|
31a | 0.023 |
31b | 0.003 |
31c | 0.012 |
31d | 0.025 |
31e | 0.005 |
31f | 0.26 |
31Â g | 0.15 |
Quinine | 0.268 |
Chloroquine | 0.020 |